Sycosis vulgaris
WikiDoc Resources for Sycosis vulgaris |
Articles |
---|
Most recent articles on Sycosis vulgaris Most cited articles on Sycosis vulgaris |
Media |
Powerpoint slides on Sycosis vulgaris |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Sycosis vulgaris at Clinical Trials.gov Trial results on Sycosis vulgaris Clinical Trials on Sycosis vulgaris at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Sycosis vulgaris NICE Guidance on Sycosis vulgaris
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Sycosis vulgaris Discussion groups on Sycosis vulgaris Patient Handouts on Sycosis vulgaris Directions to Hospitals Treating Sycosis vulgaris Risk calculators and risk factors for Sycosis vulgaris
|
Healthcare Provider Resources |
Causes & Risk Factors for Sycosis vulgaris |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2].
Synonyms and keywords: Barber's itch, sycosis barbae.
Overview
Sycosis vulgaris (also known as "Barber's itch," and "Sycosis barbae") is a cutaneous condition characterized by a chronic infection of the chin or bearded region.[1]:252[2] The irritation is caused by a deep infection of hair follicles, often by species of Staphylococcus or Propionibacterium bacteria.[3] Asymptomatic or painful and tender erythematous papules and pustules may form around coarse hairs in the beard (sycosis barbae) or the back of the neck (sycosis nuchae).
Physical examination
Gallery
Head
References
- ↑ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ↑ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set (see the picture). St. Louis: Mosby. ISBN 1-4160-2999-0.
- ↑ Nenoff, P; Haustein, UF; Hittel, N (October 2004). "Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections". Chemotherapy. 50 (4): 196–201. doi:10.1159/000081032. PMID 15452398.